To receive INTRASENSE information in real time, send a request to [email protected]
“The year 2021 marks a real milestone in the history of Intrasense, says Nicolas Reymond, Chief Executive Officer. Our strategic positioning is bearing fruit, as evidenced by the sustained growth in our turnover of +22%, marking the 4th consecutive year of growth. The very good sales momentum confirms the ability of our teams to deliver competitive, innovative and quality products with an excellent level of commercial performance in high-potential markets. We are thus pursuing our expansion strategy in France, Europe and China, through the development of our commercial activities, but also through innovation and the targeting of new markets, particularly in oncology. The fundraising carried out last June allows us to pursue this development plan with confidence, with the ambition of accelerating our performance from 2022.”